Vaxfab Enterprises Ltd Gains 20.18%: 5 Key Factors Driving the Surge

1 hour ago
share
Share Via
Vaxfab Enterprises Ltd delivered a strong weekly performance, surging 20.18% from Rs.50.55 to Rs.60.75 between 1 and 5 June 2026, significantly outperforming the Sensex which declined 0.78% over the same period. The stock hit multiple 52-week highs and an all-time high during the week, supported by robust price momentum despite mixed quarterly results and elevated valuation concerns.

Key Events This Week

1 Jun: New 52-week high at Rs.60

2 Jun: Mixed quarterly results amid negative financial trend

2 Jun: Valuation shifts signal elevated risk amid price surge

4 Jun: New 52-week high at Rs.68

4 Jun: Stock hits all-time high at Rs.68

5 Jun: Week closes at Rs.60.75 (-0.69%)

Week Open
Rs.50.55
Week Close
Rs.60.75
+20.18%
Week High
Rs.68
vs Sensex
-0.78%

1 June 2026: New 52-Week High at Rs.60 Amid Volatile Trading

Vaxfab Enterprises Ltd began the week on a strong note, hitting a new 52-week high of Rs.60 despite opening with a gap down of 4.95%. The stock demonstrated remarkable intraday volatility, swinging between a low of Rs.47 and the peak of Rs.60, with a weighted average price volatility of 12.15%. This dynamic price action resulted in an 8.47% gain for the day, closing at Rs.54.83, while the Sensex declined 0.96% to 35,077.62. The stock outperformed its Trading & Distributors sector peers by 8.81%, signalling strong relative strength. Over the past year, Vaxfab has delivered a staggering 279.57% return, vastly outpacing the Sensex’s negative 7.98% performance.

2 June 2026: Mixed Quarterly Results and Elevated Valuation Concerns

On 2 June, Vaxfab reported mixed quarterly results that revealed a negative financial trend despite record quarterly profits. The company posted its highest-ever quarterly PAT of ₹3.02 crores and EPS of ₹3.60, but core operational earnings declined sharply, with PBDIT and PBT less other income plunging to negative ₹2.55 crores and ₹2.56 crores respectively. Sales for the latest six months contracted by 48.98%, and PAT fell 60.51%, highlighting operational challenges. The stock nevertheless closed at Rs.57.46, up 4.80%, continuing its upward momentum.

Valuation metrics raised caution as the P/E ratio surged to 121.10 and P/BV to 8.46, placing the stock in the ‘risky’ valuation category. Negative EV to EBIT and EV to EBITDA multiples (-15.89 and -27.98) reflected underlying losses at the operating level. Returns on capital employed and equity were deeply negative at -67.51% and -28.11%, signalling value destruction despite the price rally. These valuation and profitability concerns contrast sharply with the stock’s strong price gains and highlight elevated risk for investors.

This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!

  • - Precise target price set
  • - Weekly selection live
  • - Position check opportunity

Check Your Position →

4 June 2026: New 52-Week and All-Time High at Rs.68 on Sustained Momentum

Vaxfab Enterprises Ltd continued its strong rally on 4 June, reaching a new 52-week and all-time high of Rs.68. The stock opened with a 15.69% gap up and closed with an 8.46% gain, significantly outperforming the Sensex which declined 0.32% that day. This marked the fourth consecutive day of gains, delivering a cumulative return of 26.11% over this period. The stock’s price now stands over 383% above its 52-week low of Rs.14.06, underscoring a remarkable appreciation within the year.

Technical indicators remain bullish, with the stock trading above all key moving averages and supported by positive MACD and Bollinger Bands on weekly and monthly charts. Despite some mild short-term caution from the Know Sure Thing indicator, the overall trend is constructive. The stock’s Mojo Score is 31.0 with a Sell rating, reflecting caution amid the strong price action.

5 June 2026: Slight Pullback to Close Week at Rs.60.75

The week concluded with a minor pullback on 5 June, as Vaxfab’s stock price declined 0.69% to close at Rs.60.75 on relatively low volume. The Sensex also fell marginally by 0.10% to 35,141.95. Despite this slight retreat, the stock’s weekly gain of 20.18% represents a significant outperformance against the benchmark index’s 0.78% decline. The pullback may reflect short-term profit-taking after the strong rally earlier in the week.

Considering Vaxfab Enterprises Ltd? Wait! SwitchER has found potentially better options in and beyond. Compare this micro-cap with top-rated alternatives now!

  • - Better options discovered
  • - + beyond scope
  • - Top-rated alternatives ready

Compare & Switch Now →

Daily Price Performance Compared to Sensex

Date Stock Price Day Change Sensex Day Change
2026-06-01 Rs.54.83 +8.47% 35,077.62 -0.96%
2026-06-02 Rs.57.46 +4.80% 35,227.64 +0.43%
2026-06-03 Rs.58.78 +2.30% 35,107.33 -0.34%
2026-06-04 Rs.61.17 +4.07% 35,175.61 +0.19%
2026-06-05 Rs.60.75 -0.69% 35,141.95 -0.10%

Key Takeaways

Strong Price Momentum: Vaxfab Enterprises Ltd surged 20.18% over the week, hitting multiple 52-week highs and an all-time high of Rs.68, vastly outperforming the Sensex’s 0.78% decline.

Mixed Financial Performance: Despite record quarterly PAT and EPS, the company faces operational challenges with declining core earnings, contracting sales, and a negative financial trend score.

Elevated Valuation Risks: The stock’s P/E ratio of 121.10 and P/BV of 8.46 place it in risky valuation territory, compounded by negative EV multiples and poor returns on capital employed and equity.

Technical Indicators Bullish: The stock trades above all key moving averages with positive MACD and Bollinger Bands, supporting the recent rally despite some short-term caution signals.

Volatility and Micro-Cap Status: Elevated intraday volatility and micro-cap classification suggest higher risk and price swings, warranting careful monitoring.

Conclusion

Vaxfab Enterprises Ltd’s week was characterised by exceptional price gains and new highs, driven by strong technical momentum and investor enthusiasm. However, the company’s mixed financial results and stretched valuation metrics introduce cautionary signals. The divergence between robust market performance and underlying operational challenges highlights the complexity of the stock’s current profile. Investors should weigh the impressive returns against the elevated risks inherent in the company’s financial health and valuation. The slight pullback on the final trading day may indicate early profit-taking, but the overall trend remains positive amid a challenging broader market environment.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News